A 5α-reductase inhibitor alcohol-containing emulsion and its preparation method and application
By developing a mellow emulsion, the existing 5α-reducing enzyme inhibitors scalp external preparations have poor stability, poor emulsification effect, and limited pharmaceutical absorption of drug transparent skin, and achieve more efficient and safer therapeutic effects.
Patent Information
- Application Number
- CN202411281626.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2025-01-28
- Estimated Expiration
- 2044-09-12
AI Technical Summary
The existing 5α-reductase inhibitor topical preparations for scalp have problems such as poor stability, poor emulsification effect, limited transdermal absorption of drugs and greasy feeling, making it difficult to meet the needs of efficient and safe treatment.
The development of a alcohol-containing emulsion, through reasonable formulation of 5α-reducing enzyme inhibitors, alcohol, oil phase, emulsifiers, diluents, and infiltration agents to form a stable emulsion system, which improves the dermatological absorption and medicinal compliance of the drug.
Achieve the stability of the lotion and the improvement of the permeable absorption effect, reduce the amount of drugs exposed throughout the body, and improve the safety of treatment and the compliance of the patient's medication.
Smart Images

Figure CN118831050B_ABST
Abstract
Citation Information
Patent Citations
Polymeric nanoparticle of finasteride and minoxidil, process of its preparation, aqueous suspension containing the same, pharmaceutical composition, and its use.
BR102012022036A2
Liquid-filled hard gel capsule pharmaceutical formulations
CN104039311A